{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:36:18Z","timestamp":1793572578384,"version":"4.5.0"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.humpath.2019.12.002","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T17:29:53Z","timestamp":1576603793000},"page":"8-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":213,"special_numbering":"C","title":["Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?"],"prefix":"10.1016","volume":"96","author":[{"given":"Andrew M","family":"Bellizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.humpath.2019.12.002_bb0005","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.humpath.2012.11.016","article-title":"Broad-spectrum immunohistochemical epithelial markers: a review","volume":"44","author":"Ordonez","year":"2013","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2019.12.002_bb0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAP.0b013e3182a2dc67","article-title":"Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry","volume":"20","author":"Bellizzi","year":"2013","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/gut.38.1.33","article-title":"Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2","volume":"38","author":"John","year":"1996","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of (177)Lu-Dotatate for Midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/PAS.0b013e31823d07f3","article-title":"Somatostatin receptor subtype 2A immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting","volume":"36","author":"Korner","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2019.12.002_bb0030","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/030089161109700514","article-title":"Detection of somatostatin receptor subtypes 2 and 5 by somatostatin receptor scintigraphy and immunohistochemistry: clinical implications in the diagnostic and therapeutic management of gastroenteropancreatic neuroendocrine tumors","volume":"97","author":"Sclafani","year":"2011","journal-title":"Tumori"},{"issue":"23","key":"10.1016\/j.humpath.2019.12.002_bb0035","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1002\/cncr.28341","article-title":"Clinicopathologic characteristics of pancreatic neuroendocrine tumors and relation of somatostatin receptor type 2A to outcomes","volume":"119","author":"Okuwaki","year":"2013","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.humpath.2019.12.002_bb0040","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/cen.12775","article-title":"Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores","volume":"83","author":"Diakatou","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"40","key":"10.1016\/j.humpath.2019.12.002_bb0045","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001281","article-title":"Somatostatin receptor SSTR-2a expression is a stronger predictor for survival than Ki-67 in pancreatic neuroendocrine tumors","volume":"94","author":"Mehta","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.humpath.2019.12.002_bb0050","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/MPA.0000000000000700","article-title":"Association between Somatostatin receptor expression and clinical outcomes in neuroendocrine tumors","volume":"45","author":"Qian","year":"2016","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.humpath.2019.12.002_bb0055","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00259-016-3486-2","article-title":"The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors","volume":"44","author":"Brunner","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl. 2","key":"10.1016\/j.humpath.2019.12.002_bb0060","first-page":"145A","article-title":"Prospective experience with routine SSTR2A immunohistochemistry in neuroendocrine epithelial neoplasms. Modern pathology : an official journal of the United States and Canadian academy of pathology","volume":"29","author":"Alkapalan","year":"2016","journal-title":"Inc."},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00191345","article-title":"Immunohistochemical distribution of chromogranins a and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract","volume":"426","author":"Fahrenkamp","year":"1995","journal-title":"Virchows Archiv : an international journal of pathology."},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0070","first-page":"275","article-title":"Immunohistochemical analysis of neural cell adhesion molecules. Differential expression in small round cell tumors of childhood and adolescence","volume":"139","author":"Garin-Chesa","year":"1991","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0075","first-page":"1300","article-title":"Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors","volume":"51","author":"Mechtersheimer","year":"1991","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0046-8177(93)90064-N","article-title":"Neural cell adhesion molecule distribution in soft tissue tumors","volume":"24","author":"Miettinen","year":"1993","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2019.12.002_bb0085","doi-asserted-by":"crossref","unstructured":"Goto Y, De Silva MG, Toscani A, Prabhakar BS, Notkins AL, Lan MS. a novel human insulinoma-associated cDNA, IA-1, encodes a protein with \"zinc-finger\" DNA-binding motifs. J Biol Chem 1992;267(21):15252\u20137.","DOI":"10.1016\/S0021-9258(18)42173-4"},{"issue":"6","key":"10.1016\/j.humpath.2019.12.002_bb0090","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/sj.emboj.7601011","article-title":"IA1 is NGN3-dependent and essential for differentiation of the endocrine pancreas","volume":"25","author":"Mellitzer","year":"2006","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/geno.2002.6800","article-title":"The zinc-finger transcription factor INSM1 is expressed during embryo development and interacts with the Cbl-associated protein","volume":"80","author":"Xie","year":"2002","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0100","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/cne.21629","article-title":"Transient expression of the conserved zinc finger gene INSM1 in progenitors and nascent neurons throughout embryonic and adult neurogenesis","volume":"507","author":"Duggan","year":"2008","journal-title":"J Comp Neurol"},{"issue":"5","key":"10.1016\/j.humpath.2019.12.002_bb0105","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/en.2009-1224","article-title":"Insulinoma-associated antigen-1 zinc-finger transcription factor promotes pancreatic duct cell trans-differentiation","volume":"151","author":"Zhang","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.humpath.2019.12.002_bb0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1749-8104-6-6","article-title":"Insm1 promotes the transition of olfactory progenitors from apical and proliferative to basal, terminally dividing and neuronogenic","volume":"6","author":"Rosenbaum","year":"2011","journal-title":"Neural Dev"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0115","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1309\/AJCPGZWXXBSNL4VD","article-title":"INSM1: a novel Immunohistochemical and molecular marker for neuroendocrine and Neuroepithelial neoplasms","volume":"144","author":"Rosenbaum","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0120","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygyno.2016.11.020","article-title":"A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: analysis of 37 cases","volume":"144","author":"Kuji","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.humpath.2019.12.002_bb0125","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1097\/PAS.0000000000000916","article-title":"INSM1 demonstrates superior performance to the individual and combined use of Synaptophysin, Chromogranin and CD56 for diagnosing neuroendocrine tumors of the thoracic cavity","volume":"41","author":"Rooper","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.12.002_bb0130","doi-asserted-by":"crossref","unstructured":"Rooper LM, Bishop JA, Westra WH. INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors. Am J Surg Pathol 2018;42(5):665\u201371.","DOI":"10.1097\/PAS.0000000000001037"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/cup.13079","article-title":"Insulinoma-associated 1: A novel nuclear marker in Merkel cell carcinoma (cutaneous neuroendocrine carcinoma)","volume":"45","author":"Rush","year":"2018","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00795-017-0167-6","article-title":"Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor","volume":"51","author":"Tanigawa","year":"2018","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.humpath.2019.12.002_bb0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.humpath.2018.10.035","article-title":"Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience","volume":"85","author":"Rodriguez","year":"2019","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0150","first-page":"508","article-title":"Neuroendocrine differentiation in poorly differentiated lung carcinomas: a light microscopic and immunohistologic study","volume":"3","author":"Visscher","year":"1990","journal-title":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/172460080502000404","article-title":"Neuroendocrine phenotype of non-small cell lung carcinoma: immunohistological evaluation and biochemical study","volume":"20","author":"Slodkowska","year":"2005","journal-title":"Int J Biol Markers"},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02739950","article-title":"Prevalence and prognostic significance of neuroendocrine differentiation in colorectal carcinomas","volume":"9","author":"Lloyd","year":"1998","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2559.2005.02047.x","article-title":"Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy","volume":"46","author":"Howe","year":"2005","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0170","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.pas.0000213319.04919.97","article-title":"Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance","volume":"31","author":"Ionescu","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00428-009-0812-0","article-title":"Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected cases","volume":"455","author":"Sterlacci","year":"2009","journal-title":"Virchows Archiv : an international journal of pathology."},{"issue":"10","key":"10.1016\/j.humpath.2019.12.002_bb0180","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1200\/JCO.1989.7.10.1398","article-title":"The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer","volume":"7","author":"Graziano","year":"1989","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0185","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/bjc.1991.301","article-title":"Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours","volume":"64","author":"Sundaresan","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2019.12.002_bb0190","doi-asserted-by":"crossref","unstructured":"Linnoila RI, Piantadosi S, Ruckdeschel JC. Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience Chest 1994;106(6 Suppl):367S\u201371S.","DOI":"10.1378\/chest.106.6.367S"},{"issue":"11","key":"10.1016\/j.humpath.2019.12.002_bb0195","first-page":"2908","article-title":"The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer","volume":"54","author":"Graziano","year":"1994","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.humpath.2019.12.002_bb0200","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1284::AID-CNCR9>3.0.CO;2-I","article-title":"Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma","volume":"77","author":"Schleusener","year":"1996","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-9896(1998100)186:2<151::AID-PATH154>3.0.CO;2-7","article-title":"Chromogranin A gene expression in non-small cell lung carcinomas","volume":"186","author":"Abbona","year":"1998","journal-title":"J Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2019.12.002_bb0210","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/cncr.11376","article-title":"Prognostic implications of neuroendocrine differentiation and hormone production in patients with stage I nonsmall cell lung carcinoma","volume":"97","author":"Pelosi","year":"2003","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.humpath.2019.12.002_bb0215","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.22985","article-title":"Molins-Lopez-Rodo L, et al. prognostic significance of synaptophysin in stage I of squamous carcinoma and adenocarcinoma of the lung","volume":"110","author":"Gonzalez-Aragoneses","year":"2007","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.humpath.2019.12.002_bb0220","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00432-009-0544-1","article-title":"Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications","volume":"135","author":"Segawa","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0225","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/1354750X.2011.560281","article-title":"Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer","volume":"16","author":"Petrovic","year":"2011","journal-title":"Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0230","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ijc.2910510205","article-title":"Chromogranin-a expression in gastric and colon cancer tissues","volume":"51","author":"Park","year":"1992","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0235","first-page":"170","article-title":"Prevalence and prognostic significance of endocrine cells in colorectal adenocarcinomas","volume":"86","author":"Lapertosa","year":"1994","journal-title":"Pathologica"},{"issue":"8","key":"10.1016\/j.humpath.2019.12.002_bb0240","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/jcp.48.8.754","article-title":"Chromogranin positive cells in colorectal carcinoma and transitional mucosa","volume":"48","author":"Mori","year":"1995","journal-title":"J Clin Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2019.12.002_bb0245","first-page":"912","article-title":"The frequency and clinical significance of neuroendocrine cells within stage III adenocarcinomas of the colon","volume":"122","author":"Foley","year":"1998","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0250","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00042737-200104000-00018","article-title":"Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer","volume":"13","author":"Grabowski","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1A","key":"10.1016\/j.humpath.2019.12.002_bb0255","first-page":"395","article-title":"Correlation between chromogranin-a expression and pathological variables in human colon carcinoma","volume":"22","author":"Indinnimeo","year":"2002","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0260","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/030089160308900111","article-title":"Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance","volume":"89","author":"Atasoy","year":"2003","journal-title":"Tumori"},{"issue":"3","key":"10.1016\/j.humpath.2019.12.002_bb0265","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1066896909332112","article-title":"The clinical significance of neuroendocrine differentiation in T3-T4 node-negative colorectal cancer","volume":"18","author":"Cho","year":"2010","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.12.002_bb0270","doi-asserted-by":"crossref","unstructured":"Suresh PK, Sahu KK, Pai RR, Sridevi HB, Ballal K, Khandelia B, et al. The Prognostic Significance of Neuroendocrine Differentiation in Colorectal Carcinomas: Our Experience. Journal of clinical and diagnostic research : JCDR. 2015;9(12):EC01\u20134.","DOI":"10.7860\/JCDR\/2015\/12800.6854"},{"key":"10.1016\/j.humpath.2019.12.002_bb0275","series-title":"Classification of neuroendocrine neoplasms of the digestive system. WHO classification of Tumours of the digestive system. 5th ed","author":"Klimstra","year":"2019"},{"key":"10.1016\/j.humpath.2019.12.002_bb0280","series-title":"Lyon: IARC","article-title":"Travis WD, Brambilla E, burke AP, Marx a, Nicholson AG, editors. WHO classification of Tumours of the lung, pleura, Thymus and heart. 4th ed","author":"In","year":"2015"},{"issue":"5","key":"10.1016\/j.humpath.2019.12.002_bb0285","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","article-title":"The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms","volume":"39","author":"Basturk","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0290","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1158\/1078-0432.CCR-15-0548","article-title":"Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from poorly differentiated neuroendocrine carcinomas","volume":"22","author":"Tang","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0295","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/PAS.0000000000000767","article-title":"High-grade neuroendocrine carcinoma of the lung with carcinoid morphology: a study of 12 cases","volume":"41","author":"Quinn","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0300","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/PAS.0b013e31826d2639","article-title":"Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases","volume":"37","author":"Huang","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2019.12.002_bb0305","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/PAS.0b013e31816bf41f","article-title":"Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus","volume":"32","author":"Maru","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0310","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41379-018-0131-6","article-title":"Identification of high-risk human papillomavirus and Rb\/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma","volume":"32","author":"Shamir","year":"2019","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2019.12.002_bb0315","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF02616821","article-title":"Composite carcinoid tumor (argentaffinoma-adenocarcinoma) of the colon: report of 2 cases","volume":"10","author":"Bates","year":"1967","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.humpath.2019.12.002_bb0320","first-page":"203","article-title":"Composite carcinoid carcinoma of the colon--a case report","volume":"31","author":"Chaturvedi","year":"1994","journal-title":"Indian J Cancer"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0325","first-page":"422","article-title":"Combined adenocarcinoma and carcinoid tumor in atrophic gastritis","volume":"32","author":"Adhikari","year":"2002","journal-title":"Ann Clin Lab Sci"},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0330","first-page":"127","article-title":"Combined carcinoid and mixed (composite) glandular - endocrine cell carcinoma of the stomach in atrophic gastritis. Journal of BUON : official journal of the Balkan union of","volume":"14","author":"Zissis","year":"2009","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0335","doi-asserted-by":"crossref","first-page":"132","DOI":"10.9738\/INTSURG-D-13-00041.1","article-title":"A case of very well-differentiated adenocarcinoma with carcinoid tumor in the ascending colon","volume":"99","author":"Yamauchi","year":"2014","journal-title":"Int Surg"},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0340","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ijc.2910310104","article-title":"Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation","volume":"31","author":"Gerdes","year":"1983","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.humpath.2019.12.002_bb0345","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1158\/0008-5472.CAN-16-0707","article-title":"Cell-cycle regulation accounts for variability in Ki-67 expression levels","volume":"77","author":"Sobecki","year":"2017","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.humpath.2019.12.002_bb0350","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00428-017-2258-0","article-title":"Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms","volume":"472","author":"Kloppel","year":"2018","journal-title":"Virchows Archiv : an international journal of pathology."},{"issue":"7611","key":"10.1016\/j.humpath.2019.12.002_bb0355","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nature18610","article-title":"Ki-67 acts as a biological surfactant to disperse mitotic chromosomes","volume":"535","author":"Cuylen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2019.12.002_bb0360","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13722","article-title":"The cell proliferation antigen Ki-67 organises heterochromatin","volume":"5","author":"Sobecki","year":"2016","journal-title":"Elife"},{"issue":"11","key":"10.1016\/j.humpath.2019.12.002_bb0365","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1097\/PAS.0000000000000089","article-title":"Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate","volume":"37","author":"McCall","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"1S","key":"10.1016\/j.humpath.2019.12.002_bb0370","first-page":"372A","article-title":"Ki-67 proliferation index in pancreatic endocrine tumors: comparison with mitotic count, interobserver variability, and impact on grading. Modern pathology : an official journal of the United States and Canadian academy of pathology","volume":"24","author":"Rege","year":"2011","journal-title":"Inc"},{"issue":"2\u20133","key":"10.1016\/j.humpath.2019.12.002_bb0375","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000369275","article-title":"Grading of neuroendocrine neoplasms: mitoses and Ki-67 are both essential","volume":"100","author":"van Velthuysen","year":"2014","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.humpath.2019.12.002_bb0380","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1309\/AJCPQ55SKOCYFZHN","article-title":"Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors","volume":"143","author":"Shi","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2019.12.002_bb0385","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1245\/s10434-017-5899-y","article-title":"Increased grade in neuroendocrine tumor metastases negatively impacts survival","volume":"24","author":"Keck","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.humpath.2019.12.002_bb0390","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/pin.12108","article-title":"Elevated Ki-67 labeling index in 'synchronous liver metastases' of well differentiated enteropancreatic neuroendocrine tumor","volume":"63","author":"Zen","year":"2013","journal-title":"Pathol Int"},{"issue":"3","key":"10.1016\/j.humpath.2019.12.002_bb0395","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/JTO.0000000000000092","article-title":"Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice","volume":"9","author":"Pelosi","year":"2014","journal-title":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_rf0380","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.pas.0000149690.75462.29","article-title":"Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients","volume":"29","author":"Pelosi","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2019.12.002_rf8380","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0000000000000300","article-title":"Interobserver variability for the WHO classification of pulmonary carcinoids","volume":"38","author":"Swarts","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2019.12.002_bb0405","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41379-019-0248-2","article-title":"Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices","volume":"32","author":"Rekhtman","year":"2019","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0410","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/annonc\/mds276","article-title":"Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study","volume":"24","author":"Sorbye","year":"2013","journal-title":"Ann Oncol"},{"issue":"20","key":"10.1016\/j.humpath.2019.12.002_bb0415","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1002\/cncr.26124","article-title":"Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy","volume":"117","author":"Welin","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0420","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000445165","article-title":"The Clinicopathologic heterogeneity of grade 3 Gastroenteropancreatic neuroendocrine neoplasms: morphological differentiation and proliferation identify different prognostic categories","volume":"104","author":"Milione","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"5","key":"10.1016\/j.humpath.2019.12.002_bb0425","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw277","article-title":"Design and validation of the GI-NEC score to prognosticate overall survival in patients with high-grade gastrointestinal neuroendocrine carcinomas","volume":"109","author":"Lamarca","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.humpath.2019.12.002_bb0430","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/PAS.0000000000000662","article-title":"A practical approach to the classification of WHO grade 3 (G3) well-differentiated neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of the pancreas","volume":"40","author":"Tang","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2019.12.002_bb0435","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0440","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/MPA.0b013e31828e34a4","article-title":"Consensus guidelines for the management and treatment of neuroendocrine tumors","volume":"42","author":"Kunz","year":"2013","journal-title":"Pancreas"},{"issue":"6","key":"10.1016\/j.humpath.2019.12.002_bb0445","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/MPA.0000000000000846","article-title":"The surgical Management of Small Bowel Neuroendocrine Tumors: consensus guidelines of the north American neuroendocrine tumor society","volume":"46","author":"Howe","year":"2017","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0450","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/1097-0142(1971)28:4<990::AID-CNCR2820280424>3.0.CO;2-K","article-title":"Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases","volume":"28","author":"Soga","year":"1971","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.humpath.2019.12.002_bb0455","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archsurg.2010.10","article-title":"Identification of unknown primary tumors in patients with neuroendocrine liver metastases","volume":"145","author":"Wang","year":"2010","journal-title":"Arch Surg"},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0460","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.surg.2016.05.055","article-title":"Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors","volume":"161","author":"Keck","year":"2017","journal-title":"Surgery"},{"issue":"Supplement 1","key":"10.1016\/j.humpath.2019.12.002_bb0465","first-page":"237A","article-title":"Comparison of serotonin to the Midgut marker CDX2 to assign site of origin in a well-differentiated neuroendocrine tumor","volume":"98","author":"Roquiz","year":"2018","journal-title":"Lab Invest"},{"issue":"7","key":"10.1016\/j.humpath.2019.12.002_bb0470","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/modpathol.2013.40","article-title":"ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin","volume":"26","author":"Agaimy","year":"2013","journal-title":"Mod Pathol"},{"issue":"Supplement 2","key":"10.1016\/j.humpath.2019.12.002_bb0475","first-page":"160A","article-title":"Extensive evaluation of immunohistochemistry to assign site of origin in well-differentiated neuroendocrine tumors: a study of 10 markers in 265 tumors","volume":"27","author":"Stashek","year":"2014","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2019.12.002_bb0480","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00418-011-0866-3","article-title":"Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors","volume":"136","author":"Lorenzo","year":"2011","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0485","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/his.13943","article-title":"SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas","volume":"76","author":"Bellizzi","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2019.12.002_bb0490","doi-asserted-by":"crossref","unstructured":"Marinoni I, Kurrer AS, Vassella E, Dettmer M, Rudolph T, Banz V, et al. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Gastroenterology. 2014;146(2):453\u201360 e5.","DOI":"10.1053\/j.gastro.2013.10.020"},{"issue":"6","key":"10.1016\/j.humpath.2019.12.002_bb0495","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1158\/1078-0432.CCR-16-1147","article-title":"Alternative lengthening of telomeres in primary pancreatic neuroendocrine tumors is associated with aggressive clinical behavior and poor survival","volume":"23","author":"Kim","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0500","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/1078-0432.CCR-16-1113","article-title":"Alternative lengthening of telomeres and loss of DAXX\/ATRX expression predicts metastatic disease and poor survival in patients with pancreatic neuroendocrine tumors","volume":"23","author":"Singhi","year":"2017","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research."},{"key":"10.1016\/j.humpath.2019.12.002_bb0505","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.humpath.2018.07.032","article-title":"ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors","volume":"82","author":"Chou","year":"2018","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2019.12.002_bb0510","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12022-018-9530-y","article-title":"Clinical and pathologic characteristics of pulmonary carcinoid tumors in central and peripheral locations","volume":"29","author":"Papaxoinis","year":"2018","journal-title":"Endocr Pathol"},{"issue":"Supplement 1","key":"10.1016\/j.humpath.2019.12.002_bb0515","first-page":"236A","article-title":"Orthopedia Homeobox (OTP) expression in a well-differentiated neuroendocrine tumor supports a Bronchopulmonary origin","volume":"98","author":"Pelletier","year":"2018","journal-title":"Lab Invest"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0520","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/PAI.0000000000000563","article-title":"Clusterin in neuroendocrine epithelial neoplasms: absence of expression in a well-differentiated tumor suggests a Jejunoileal origin","volume":"26","author":"Czeczok","year":"2018","journal-title":"Applied immunohistochemistry & molecular morphology : AIMM"},{"issue":"9","key":"10.1016\/j.humpath.2019.12.002_bb0525","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/1097-0142(19921101)70:9<2268::AID-CNCR2820700910>3.0.CO;2-X","article-title":"Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin","volume":"70","author":"Viale","year":"1992","journal-title":"Cancer"},{"issue":"6021","key":"10.1016\/j.humpath.2019.12.002_bb0530","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"issue":"7643","key":"10.1016\/j.humpath.2019.12.002_bb0535","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.humpath.2019.12.002_bb0540","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1172\/JCI67963","article-title":"The genomic landscape of small intestine neuroendocrine tumors","volume":"123","author":"Banck","year":"2013","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0545","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/path.4853","article-title":"Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D","volume":"241","author":"Simbolo","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2019.12.002_bb0550","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1038\/ncomms7140","article-title":"Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas","volume":"6","author":"Fishbein","year":"2015","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0555","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/his.12927","article-title":"Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas","volume":"69","author":"Ikemura","year":"2016","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.humpath.2019.12.002_bb0560","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/NEN.0000000000000167","article-title":"Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade","volume":"74","author":"Mur","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6041","key":"10.1016\/j.humpath.2019.12.002_bb0565","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1207313","article-title":"Altered telomeres in tumors with ATRX and DAXX mutations","volume":"333","author":"Heaphy","year":"2011","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0570","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/cncr.31124","article-title":"Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: a SEER database analysis of 162,983 cases","volume":"124","author":"Dasari","year":"2018","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0575","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2019.12.002_bb0580","doi-asserted-by":"crossref","unstructured":"Paulson KG, Park SY, Vandeven NA, Lachance K, Thomas H, Chapuis AG, et al. Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics. Journal of the American Academy of Dermatology. 2018;78(3):457\u201363 e2.","DOI":"10.1016\/j.jaad.2017.10.028"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0585","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I","article-title":"Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms","volume":"68","author":"Moertel","year":"1991","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.humpath.2019.12.002_bb0590","article-title":"Efficacy and safety of first-line Avelumab treatment in patients with stage IV metastatic Merkel cell carcinoma: a preplanned interim analysis of a clinical trial","volume":"4","author":"D'Angelo","year":"2018","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.humpath.2019.12.002_bb0595","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1200\/JCO.18.01896","article-title":"Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving Pembrolizumab as first-line therapy","volume":"37","author":"Nghiem","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2019.12.002_bb0600","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Merkel Cell Carcinoma.Version 1.2020."},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0605","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000443172","article-title":"ENETS consensus guidelines for high-grade Gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas","volume":"103","author":"Garcia-Carbonero","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.humpath.2019.12.002_bb0610","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Neuroendocrine and Adrenal Tumors.Version 1.2019."},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0615","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2017.12.001","article-title":"A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix","volume":"148","author":"Castle","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.humpath.2019.12.002_bb0620","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/PAS.0b013e31823f2f17","article-title":"HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior","volume":"36","author":"Kraft","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2019.12.002_bb0625","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/his.13758","article-title":"Neurofilament is superior to cytokeratin 20 in supporting cutaneous origin for neuroendocrine carcinoma","volume":"74","author":"Stanoszek","year":"2019","journal-title":"Histopathology"},{"issue":"Supplement 2","key":"10.1016\/j.humpath.2019.12.002_bb0630","first-page":"132A","article-title":"Immunohistochemistry for Merkel cell Polyomavirus large T antigen (CM2B4) and Neurofilament protein adds little value to CK20 and TTF-1 in the distinction of cutaneous and visceral high-grade neuroendocrine carcinomas","volume":"27","author":"Czeczok","year":"2014","journal-title":"Mod Pathol"},{"issue":"5866","key":"10.1016\/j.humpath.2019.12.002_bb0635","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal integration of a polyomavirus in human Merkel cell carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.humpath.2019.12.002_bb0640","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1158\/0008-5472.CAN-15-0702","article-title":"The distinctive mutational spectra of Polyomavirus-negative Merkel cell carcinoma","volume":"75","author":"Harms","year":"2015","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.humpath.2019.12.002_bb0645","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.18632\/oncotarget.6494","article-title":"Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy","volume":"7","author":"Goh","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.humpath.2019.12.002_bb0650","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ijc.24510","article-title":"Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors","volume":"125","author":"Shuda","year":"2009","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.humpath.2019.12.002_bb0655","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/PAS.0b013e3181aa30a5","article-title":"Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas","volume":"33","author":"Busam","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2019.12.002_bb0660","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1309\/AJCPWW2URZ9JKQJU","article-title":"The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study","volume":"141","author":"Dragomir","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2019.12.002_bb0665","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/modpathol.2008.118","article-title":"MASH1: a useful marker in differentiating pulmonary small cell carcinoma from Merkel cell carcinoma","volume":"21","author":"Ralston","year":"2008","journal-title":"Mod Pathol"},{"issue":"7563","key":"10.1016\/j.humpath.2019.12.002_bb0670","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.humpath.2019.12.002_bb0675","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-15-2946","article-title":"Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets","volume":"22","author":"Rekhtman","year":"2016","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research."},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0680","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41467-018-03099-x","article-title":"Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors","volume":"9","author":"George","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2019.12.002_bb0685","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1038\/ncomms7377","article-title":"RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer","volume":"6","author":"Niederst","year":"2015","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.humpath.2019.12.002_bb0690","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1172\/JCI44239","article-title":"The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression","volume":"120","author":"Sharma","year":"2010","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0695","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","article-title":"Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors","volume":"36","author":"Yachida","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0700","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/modpathol.2016.220","article-title":"Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas","volume":"30","author":"Jesinghaus","year":"2017","journal-title":"Mod Pathol"},{"issue":"Supplement 2","key":"10.1016\/j.humpath.2019.12.002_bb0705","first-page":"540A","article-title":"p53 and Rb immunohistochemistry as molecular surrogates show distinctive patterns in visceral and cutaneous poorly differentiated neuroendocrine carcinomas","volume":"32","author":"Bellizzi","year":"2019","journal-title":"Mod Pathol"},{"issue":"Supplement 1","key":"10.1016\/j.humpath.2019.12.002_bb0710","first-page":"236A","article-title":"CXCR4 is highly expressed by poorly differentiated neuroendocrine carcinoma","volume":"98","author":"Pelletier","year":"2018","journal-title":"A Novel Diagnostic, Prognostic, and Potential Therapeutic Target Lab Invest"},{"issue":"6","key":"10.1016\/j.humpath.2019.12.002_bb0715","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00000478-200206000-00023","article-title":"Usefulness of beta-catenin immunostaining for the differential diagnosis of solid-pseudopapillary neoplasm of the pancreas","volume":"26","author":"Tanaka","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2019.12.002_bb0720","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/modpathol.2014.40","article-title":"Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas","volume":"27","author":"Singhi","year":"2014","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2019.12.002_bb0725","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00428-014-1657-8","article-title":"Acinar cell carcinomas of the pancreas: a molecular analysis in a series of 57 cases","volume":"465","author":"Bergmann","year":"2014","journal-title":"Virchows Archiv : an international journal of pathology"},{"issue":"12","key":"10.1016\/j.humpath.2019.12.002_bb0730","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/2159-8290.CD-14-0617","article-title":"Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes","volume":"4","author":"Chmielecki","year":"2014","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.humpath.2019.12.002_bb0735","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/MPA.0b013e318264d073","article-title":"Mixed acinar-endocrine carcinoma of the pancreas: new clinical and pathological features in a contemporary series","volume":"42","author":"Yu","year":"2013","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0740","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00428-008-0710-x","article-title":"The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia","volume":"454","author":"La Rosa","year":"2009","journal-title":"Virchows Archiv : an international journal of pathology."},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0745","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PAS.0000000000000943","article-title":"Diagnostic and prognostic biomarkers of adrenal cortical carcinoma","volume":"42","author":"Mete","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0750","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1158\/1078-0432.CCR-10-2006","article-title":"Beta-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma","volume":"17","author":"Gaujoux","year":"2011","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.humpath.2019.12.002_bb0755","article-title":"Landscape of microsatellite instability across 39 Cancer types","volume":"2017","author":"Bonneville","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.humpath.2019.12.002_bb0760","doi-asserted-by":"crossref","unstructured":"Al-Khafaji B, Noffsinger AE, Miller MA, DeVoe G, Stemmermann GN, Fenoglio-Preiser C. Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors. Hum Pathol 1998;29(9):992\u20139.","DOI":"10.1016\/S0046-8177(98)90206-4"},{"issue":"2","key":"10.1016\/j.humpath.2019.12.002_bb0765","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2559.2011.03747.x","article-title":"Sox10-positive sustentacular cells in neuroendocrine carcinoma of the lung","volume":"58","author":"Tsuta","year":"2011","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.humpath.2019.12.002_bb0770","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"Supplement 2","key":"10.1016\/j.humpath.2019.12.002_bb0775","first-page":"567A","volume":"32","author":"Sachs","year":"2019","journal-title":"Tyrosine Hydroxylase is Superior to GATA-3 for the Diagnosis of Pheochromocytoma\/Paraganglioma Among Neuroendocrine Neoplasms Mod Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2019.12.002_bb0780","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/PAP.0b013e31825c6bc6","article-title":"Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications","volume":"19","author":"Barletta","year":"2012","journal-title":"Adv Anat Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719302291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719302291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:36:30Z","timestamp":1758645390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817719302291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":157,"alternative-id":["S0046817719302291"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2019.12.002","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2019.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}